Bioceres Crop Solutions (BIOX) Projected to Post Earnings on Tuesday

Bioceres Crop Solutions (NASDAQ:BIOX) is anticipated to post its Q3 2026 results before the market opens on Tuesday, May 12th. Analysts expect Bioceres Crop Solutions to post earnings of ($0.05) per share and revenue of $54.50 million for the quarter. Individuals may review the information on the company’s upcoming Q3 2026 earning report for the latest details on the call scheduled for Tuesday, May 12, 2026 at 8:30 AM ET.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings results on Friday, March 13th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.15). Bioceres Crop Solutions had a negative net margin of 82.83% and a negative return on equity of 22.43%. The company had revenue of $73.67 million during the quarter, compared to the consensus estimate of $104.55 million.

Bioceres Crop Solutions Trading Down 0.5%

BIOX opened at $0.47 on Friday. Bioceres Crop Solutions has a 1-year low of $0.35 and a 1-year high of $5.18. The company has a current ratio of 0.90, a quick ratio of 0.69 and a debt-to-equity ratio of 0.32. The company has a market cap of $29.73 million, a P/E ratio of -0.13 and a beta of 0.39. The company has a fifty day moving average price of $0.51 and a two-hundred day moving average price of $1.05.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on BIOX. Wall Street Zen downgraded shares of Bioceres Crop Solutions from a “hold” rating to a “sell” rating in a research report on Saturday, April 4th. Weiss Ratings downgraded shares of Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research report on Wednesday. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Bioceres Crop Solutions currently has a consensus rating of “Hold” and an average price target of $4.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Jones Financial Companies Lllp boosted its holdings in Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares during the last quarter. Bank of America Corp DE boosted its holdings in Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after purchasing an additional 3,735 shares during the last quarter. PDT Partners LLC boosted its holdings in Bioceres Crop Solutions by 58.9% during the second quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after purchasing an additional 10,449 shares during the last quarter. Virtu Financial LLC purchased a new position in Bioceres Crop Solutions in the third quarter valued at about $40,000. Finally, Invesco Ltd. purchased a new position in Bioceres Crop Solutions in the fourth quarter valued at about $45,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.